Sun Pharma Advanced Research Company Ltd., incorporated in 2006, is a mid-cap company (having a market capitalization of Rs 8293.47 Crore) operating in the pharmaceutical sector.
Major products/revenue segments of Sun Pharma Advanced Research Company Ltd. include the sale of services for the year ending March 31, 2021.
For the quarter ended 30-09-2021, the company reported total standalone revenue of Rs 33.85 Crore, up 48.53% from last quarter, total revenue of Rs 22.79 Crore and in up 65.44% from the same quarter last year, total revenue of Rs 20.46 Crore. The company reported net profit after tax of Rs -55.14 Crore last quarter.
The daily and weekly RSI strength indicator is in bullish mode with a positive crossover supporting the growing strength.
(Disclaimer: The recommendations given in this section or any report attached hereto are written by an external party. The views expressed are those of the respective authors/entities. These do not represent the views of Economic Times (ET). AND does not warrant, for, endorse any of its content and hereby disclaims all warranties, express or implied, relating thereto.Please consult your financial adviser and seek independent advice.